Application 219116
- Type
- ANDA
- Sponsor
- QILU PHARM HAINAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUMETANIDE | BUMETANIDE | INJECTABLE;INJECTION | 0.25MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219116-001 | BUMETANIDE | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219116-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | 2680178bc6a6… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219116-001 | BUMETANIDE | 0.25MG/ML | INJECTABLE / INJECTION | AP | 2024-09-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219116-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219116-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219116-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A219116-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A219116-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A219116-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A219116-001 | AP | 1 | 2680178bc6a6… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A219116-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A219116-001 | AP | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219116-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bumetanide | BUMETANIDE | Mullan Pharmaceutical Inc. | b7cd724b-817b-4b45-8133-1ebf505867e7 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 219116 ANDA219116 |
| Bumetanide | BUMETANIDE | Qilu Pharmaceutical Co., Ltd. | ef5fe12a-f8ee-4ba7-932b-51bbaccf6575 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | 219116 ANDA219116 |